These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 15524338)

  • 1. Pharmacogenetics and cardiovascular disease management.
    Weston CF
    Hosp Med; 2004 Oct; 65(10):594-8. PubMed ID: 15524338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethnic differences in cardiovascular drug response: potential contribution of pharmacogenetics.
    Johnson JA
    Circulation; 2008 Sep; 118(13):1383-93. PubMed ID: 18809808
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacogenomics in cardiovascular disease: the role of single nucleotide polymorphisms in improving drug therapy.
    Mango R; Vecchione L; Raso B; Borgiani P; Brunetti E; Mehta JL; Lauro R; Romeo F; Novelli G
    Expert Opin Pharmacother; 2005 Dec; 6(15):2565-76. PubMed ID: 16316297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenetics, pharmacogenomics, and cardiovascular therapeutics: the way forward.
    Terra SG; Johnson JA
    Am J Cardiovasc Drugs; 2002; 2(5):287-96. PubMed ID: 14727958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic review on pharmacogenetics in cardiovascular disease: is it ready for clinical application?
    Verschuren JJ; Trompet S; Wessels JA; Guchelaar HJ; de Maat MP; Simoons ML; Jukema JW
    Eur Heart J; 2012 Jan; 33(2):165-75. PubMed ID: 21804109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular pharmacogenetics.
    Myburgh R; Hochfeld WE; Dodgen TM; Ker J; Pepper MS
    Pharmacol Ther; 2012 Mar; 133(3):280-90. PubMed ID: 22123178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular pharmacogenomics and individualized drug therapy.
    Pereira NL; Weinshilboum RM
    Nat Rev Cardiol; 2009 Oct; 6(10):632-8. PubMed ID: 19707183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomics and the prospects of existing and emerging therapeutics for cardiovascular diseases.
    Zaiou M; Benachour H; Marteau JB; Visvikis-Siest S; Siest G
    Curr Pharm Des; 2009; 15(27):3193-206. PubMed ID: 19754391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular pharmacogenomics: the future of cardiovascular therapeutics?
    Roden DM
    Can J Cardiol; 2013 Jan; 29(1):58-66. PubMed ID: 23200096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Implementation of Cardiovascular Pharmacogenomics.
    Pereira NL; Stewart AK
    Mayo Clin Proc; 2015 Jun; 90(6):701-4. PubMed ID: 26046404
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacogenetics of chronic cardiovascular drugs: applications and implications.
    Zineh I; Johnson JA
    Expert Opin Pharmacother; 2006 Aug; 7(11):1417-27. PubMed ID: 16859425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenetics and cardiovascular disease: impact on drug response and applications to disease management.
    Humma LM; Terra SG
    Am J Health Syst Pharm; 2002 Jul; 59(13):1241-52. PubMed ID: 12116890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The PPAR genes, cardiovascular disease and the emergence of PPAR pharmacogenetics.
    Cresci S
    Expert Opin Pharmacother; 2005 Dec; 6(15):2577-91. PubMed ID: 16316298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic relevance of pharmacogenetic factors in cardiovascular medicine.
    Nakagawa K; Ishizaki T
    Pharmacol Ther; 2000 Apr; 86(1):1-28. PubMed ID: 10760544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacogenomics and pharmacoproteomics: a strategy for cardio-vascular drugs].
    Siest G; Marteau JB; Maumus S; Berrahmoune H; Jeannesson E; Samara A; Batt AM; Visvikis-Siest S
    Ann Pharm Fr; 2007 May; 65(3):203-10. PubMed ID: 17489077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenetic implications of the eNOS polymorphisms for cardiovascular action drugs.
    Silva PS; Lacchini R; Gomes Vde A; Tanus-Santos JE
    Arq Bras Cardiol; 2011 Feb; 96(2):e27-34. PubMed ID: 21445464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenomic Challenges in Cardiovascular Diseases: Examples of Drugs and Considerations for Future Integration in Clinical Practice.
    Chatelin J; Stathopoulou MG; Arguinano AA; Xie T; Visvikis-Siest S
    Curr Pharm Biotechnol; 2017; 18(3):231-241. PubMed ID: 28117005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular disease strategies--directions after the human genome.
    Barone FC
    Curr Opin Investig Drugs; 2006 Sep; 7(9):789-91. PubMed ID: 17002255
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pharmacogenomics of cardiovascular pharmacology].
    Tanaka T; Oka T; Iwao H
    Nihon Yakurigaku Zasshi; 2006 Sep; 128(3):130-2. PubMed ID: 16971774
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacogenomics and cardiology: improving treatment with existing drugs.
    Sorrentino MJ; O'Donnell PH
    Pharmacogenomics; 2015; 16(11):1223-6. PubMed ID: 26369612
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.